Evidence map›Paper›PMID 34663870›Full record

ArticleScientific reports2021

Delicate balance among thermal stability, binding affinity, and conformational space explored by single-domain V

Emina Ikeuchi, Daisuke Kuroda, Makoto Nakakido, Akikazu Murakami, Kouhei Tsumoto

Abstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Nanobodies targeting hnRNPA2/B1 and tau.bioRxiv : the preprint server for biology · 2025
    Article
  6. Improving the solubility of single domain antibodies using VH-like hallmark residues.Protein science : a publication of the Protein Society · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. General Trends of theInternational journal of molecular sciences · 2023
    Article
  16. Application Progress of the Single Domain Antibody in Medicine.International journal of molecular sciences · 2023
    Review
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Emina Ikeuchi *Department of Bioengineering, School of Engineering, The University of Tokyo, Tokyo, 108-8639, Japan.
Daisuke Kuroda *Department of Bioengineering, School of Engineering, The University of Tokyo, Tokyo, 108-8639, Japan.
Makoto NakakidoDepartment of Bioengineering, School of Engineering, The University of Tokyo, Tokyo, 108-8639, Japan.
Akikazu MurakamiDepartment of Parasitology and Immunopathoetiology, Graduate School of Medicine, University of the Ryukyus, Okinawa, 903-0215, Japan.
Kouhei TsumotoDepartment of Bioengineering, School of Engineering, The University of Tokyo, Tokyo, 108-8639, Japan. tsumoto@bioeng.t.u-tokyo.ac.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The high binding affinities and specificities of antibodies have led to their use as drugs and biosensors. Single-domain V

Indexed as

Amino Acid SequenceAnimalsAntibodiesBiophysical PhenomenaHumansMolecular ConformationMolecular Dynamics SimulationProtein BindingSingle-Chain AntibodiesSingle-Domain AntibodiesAntibodiesSingle-Chain AntibodiesSingle-Domain Antibodies

Identifiers

PMID34663870
PMCPMC8523659

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.